State-of-the-art consensus on non-transvenous implantable cardioverter-defibrillator therapy

被引：6

作者：

Schukro, Christoph ^{[1
]}

Santer, David ^{[2
]}

Prenner, Gunther ^{[3
]}

Stuehlinger, Markus ^{[4
]}

Martinek, Martin ^{[5
]}

Teubl, Alexander ^{[6
]}

Moertl, Deddo ^{[7
]}

Schwarz, Stefan ^{[8
]}

Nuernberg, Michael ^{[9
]}

Fiedler, Lukas ^{[6
]}

Hatala, Robert ^{[10
,11
]}

Khazen, Cesar ^{[12
]}

机构：

[1] Med Univ Vienna, Dept Internal Med 2, Div Cardiol, Wahringer Gurtel 18-20, A-1090 Vienna, Austria

[2] Univ Hosp Basel, Dept Cardiac Surg, Basel, Switzerland

[3] Med Univ Graz, Dept Internal Med, Div Cardiol, Graz, Austria

[4] Med Univ Innsbruck, Dept Internal Med 3, Innsbruck, Austria

[5] Ordensklinikum Linz Elisabethinen Hosp, Dept Internal Med 1, Linz, Austria

[6] Wiener Neustadt State Hosp, Dept Internal Med 3, Wiener Neustadt, Austria

[7] Univ Hosp St Polten, Dept Internal Med 3, St Polten, Austria

[8] Kepler Univ Hosp Linz, Dept Internal Med 1, Linz, Austria

[9] Wilhelminen Hosp Vienna, Dept Internal Med 3, Vienna, Austria

[10] Natl Inst Cardiovasc Dis, Dept Arrhythmias & Cardiac Pacing, Bratislava, Slovakia

[11] Slovak Med Univ, Bratislava, Slovakia

[12] Med Univ Vienna, Dept Surg, Div Cardiac Surg, Vienna, Austria

来源：

CLINICAL CARDIOLOGY | 2020年 / 43卷 / 10期

关键词：

consensus document; non-transvenous implantable cardioverter defibrillator; recommendations; subcutaneous implantable cardioverter defibrillator; RANDOMIZED CONTROLLED-TRIAL; REDUCED EJECTION FRACTION; VENTRICULAR-FIBRILLATION; SHOCK EFFICACY; RISK-FACTORS; ICD; SAFETY; ELIGIBILITY; PERFORMANCE; PREDICTORS;

D O I：

10.1002/clc.23432

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Within the last decade, implantable cardioverter-defibrillator (ICD) systems with non-transvenous leads were developed in order to minimize complications related to the cardiovascular position of transvenous ICD leads. This national expert consensus gives an overview of potential indications for the implantation of non-transvenous ICD systems, and provides specific recommendations for implantation, follow-up, and complication management in patients with subcutaneous ICD. Regarding particular issues like the necessity for shock efficacy testing, or the clinical outcome as compared to transvenous ICD, randomized data are expected in the near future.

引用

页码：1084 / 1092

页数：9

共 50 条

[1] Successful extravascular implantable cardioverter-defibrillator implantation in a patient with recurrent transvenous implantable cardioverter-defibrillator erosion
Robinson, Andrea
Billakanty, Sreedhar
Fu, Eugene
Amin, Anish
HEART RHYTHM O2, 2024, 5 (04): : 243 - 245
[2] Transvenous vs. non-transvenous implantable cardioverter-defibrillator: a meta-analysis of comparative outcome studies in the pediatric and young adult population
Carillo, Anna Lisa
Ricci, Fabrizio
Radico, Francesco
Ianni, Umberto
Archilletti, Federico
De Innocentiis, Carlo
Procopio, Antonio
Faustino, Massimiliano
Zimarino, Marco
Pierdomenico, Sante Donato
Gallina, Sabina
Renda, Giulia
EUROPEAN HEART JOURNAL SUPPLEMENTS, 2019, 21 (0J) : J9 - J9
[3] Risk of Failure of Transvenous Implantable Cardioverter-Defibrillator Leads
Borleffs, C. Jan Willem
van Erven, Lieselot
van Bommel, Rutger J.
van der Velde, Enno T.
van der Wall, Ernst E.
Bax, Jeroen J.
Rosendaal, Frits R.
Schalij, Martin J.
CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY, 2009, 2 (04): : 411 - 416
[4] INFECTIVE ENDOCARDITIS OF THE TRANSVENOUS LEAD OF AN IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR
WERNER, GS
GONSKA, BD
HERSE, B
KREUZER, H
ZEITSCHRIFT FUR KARDIOLOGIE, 1995, 84 (01): : 51 - 54
[5] ANESTHESIA FOR TRANSVENOUS INSERTION OF AN AUTOMATIC IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR
CASHMAN, JN
GARCIARODRIGUEZ, C
LAMOND, C
ANAESTHESIA, 1992, 47 (08) : 720 - 721
[6] The subcutaneous implantable cardioverter defibrillator: state-of-the-art review
McLeod, Christopher J.
Boersma, Lucas
Okamura, Hideo
Friedman, Paul A.
EUROPEAN HEART JOURNAL, 2017, 38 (04) : 247 - 257
[7] SHOCK WITHOUT WIRES: A LOOK AT SUBCUTANEOUS IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR COMPARED TO TRANSVENOUS IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR FOR VENTRICULAR ARRHYTHMIAS
Guice, K. C.
Raja, J.
Oberoi, M.
Khouzam, R.
JOURNAL OF INVESTIGATIVE MEDICINE, 2021, 69 (02) : 493 - 493
[8] Shock Without Wires: A Look at Subcutaneous Implantable Cardioverter-Defibrillator Compared to Transvenous Implantable Cardioverter-Defibrillator for Ventricular Arrhythmias
Raja, Joel
Guice, Kenneth
Oberoi, Mansi
Whitwell, Samantha
Asbeutah, Abdul Aziz
Russell, Alex
Khouzam, Rami N.
CURRENT PROBLEMS IN CARDIOLOGY, 2022, 47 (09)
[9] Meta-Analysis on Subcutaneous Versus Transvenous Implantable Cardioverter-Defibrillator Therapy
Kheiri, Babikir
Howell, Stacey
Nazer, Babak
AMERICAN JOURNAL OF CARDIOLOGY, 2023, 200 : 202 - 203
[10] Subcutaneous vs Transvenous Implantable Cardioverter-Defibrillator Therapy in Patients With Tetralogy of Fallot
Waldmann, Victor
Marquie, Christelle
Bouzeman, Abdeslam
Duthoit, Guillaume
Thambo, Jean-Benoit
Koutbi, Linda
Maltret, Alice
Pasquie, Jean-Luc
Combes, Nicolas
Marijon, Eloi
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2022, 80 (17) : 1701 - 1703

← 1 2 3 4 5 →